Markets, as they land
Filings, big moves, results and the day's finance news in one place. Updated every few minutes.
Latest finance news All news
- AI crush is powering one stock to sky-high valuations
- DraftKings' expensive bet on prediction markets is crushing its stock
- What's next for your portfolio after the decline in Big Tech stocks?
- OpenAI wants to win over data-center opponents by calling them 'compute campuses' and promising local benefits
- 'We're losing to cottage cheese': The protein-maxxing craze is hurting cream cheese sales
- The AI 'credit card' is getting costlier as CoreWeave bond yield tops 16%
- Layoffs with dignity? Why these tech companies are offering free laptops and LinkedIn Premium.
- US tech stock rout: is the AI bubble bursting?
- Bill Gates believes a billionaire's tax is the only option in the age of AI, and 'whatever's left over' can be used as a philanthropic safety net
- Nvidia, AMD and other chip stocks rebound. Is the 'violent' AI selloff over?
- 'A master class in how to handle layoffs': Canva is restructuring 22% of its workforce, and LinkedIn is applauding the exit package
- These three stars need to align before investors rush back into stocks, Bank of America strategist says
- Watch: Jim Cramer shares his next investing moves for this tough market
- AI stocks climb after trillions wiped from market values
New filings All filings
MAR Marriott International: President & CEO Anthony Capuano sold $26.6M of stock at about $420.12 a share.
Read the filingDKNG DraftKings reported its results. Shares -27.4% today.
Why: "DraftKings shares plunge as earnings miss and 2027 outlook disappoints" (Proactive)
New 52-week low. Volume already 2.9x a normal day.
Insider cluster: LYEL Lyell Immunopharma
2 insiders bought $50.0M of shares in the last 14 days.
Corvane logs every insider cluster and scores it against SPY after 5, 20 and 60 days.
HUM Humana reported its results. Shares +4.7% today.
Why: "Humana (HUM) Reports 26% Revenue Growth in Q3, Raises Earnings G" (GuruFocus)
MRNA Moderna reported its results. Shares +8.8% today.
Why: "MRNA Q3 Earnings Beat on COVID Sales, Raises '26 Outlook, Stock Rises" (Zacks Investment Research) New 52-week high.
Biggest moves All movers
Filings, big movers and results after the US close. Free, no spam, leave any time.
Sign up free